Nobel Prize Honors Groundbreaking Immune System Discoveries

This year's Nobel Prize in Physiology or Medicine has been awarded for transformative findings that clarify how the immune system targets harmful infections while protecting the body's own cells.

A trio of esteemed researchers—from Japan Shimon Sakaguchi and American scientists Mary Brunkow and Dr. Ramsdell—share this honor.

Their work identified unique "sentinels" within the immune system that remove rogue defense cells that could harming the body.

The discoveries are now enabling innovative therapies for immune disorders and cancer.

The winners will share a monetary award worth 11 million Swedish kronor.

Decisive Discoveries

"The work has been decisive for comprehending how the body's defenses operates and why we don't all develop severe autoimmune diseases," commented the chair of the Nobel Committee.

The team's research address a fundamental mystery: In what way does the immune system defend us from countless invaders while keeping our own tissues intact?

The immune system employs immune cells that scan for signs of disease, including pathogens and bacteria it has not met before.

Such defenders utilize detectors—called receptors—that are produced by chance in countless combinations.

That provides the defense network the ability to combat a wide array of invaders, but the unpredictability of the mechanism inevitably creates white blood cells that can attack the host.

Protectors of the Immune System

Scientists earlier knew that some of these harmful defense cells were eliminated in the immune organ—where immune cells mature.

The latest award recognizes the identification of T-reg cells—described as the immune system's "security guards"—which travel through the system to neutralize other defenders that assault the healthy cells.

We know that this process malfunctions in self-attack conditions such as juvenile diabetes, MS, and RA.

The prize committee stated, "The findings have established a novel area of research and accelerated the development of innovative therapies, for instance for cancer and autoimmune diseases."

In cancer, T-regs block the system from attacking the growth, so research are focused on lowering their quantity.

In self-attack disorders, trials are exploring increasing T-reg cells so the organism is no longer under attack. A similar approach could also be useful in reducing the risks of transplanted organ failure.

Innovative Studies

Prof Sakaguchi, of Osaka University, performed tests on mice that had their thymus extracted, causing self-attack conditions.

The researcher demonstrated that introducing immune cells from healthy animals could prevent the disease—suggesting there was a mechanism for preventing defenders from attacking the body.

Mary Brunkow, from the a research center in a US city, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in a California city, were investigating an inherited immune disorder in rodents and people that led to the identification of a genetic factor vital for the way T-regs function.

"Their pioneering research has revealed how the immune system is controlled by T-reg cells, stopping it from accidentally targeting the healthy cells," said a leading physiology specialist.

"This work is a remarkable example of how fundamental biological research can have far-reaching consequences for human health."